Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveys (Q38232098)

31 August 2017

title

Issues and considerations in the use of serologic biomarkers for classifying vaccination history in household surveys (English)

1 reference

31 August 2017

0 references

0 references

Adam MacNeil

1

1 reference

31 August 2017

Chung-Won Lee

series ordinal

2

1 reference

31 August 2017

Vance Dietz

series ordinal

3

1 reference

31 August 2017

language of work or name

English

0 references

publication date

18 July 2014

1 reference

31 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

31 August 2017

volume

32

1 reference

31 August 2017

issue

39

1 reference

31 August 2017

page(s)

4893-4900

1 reference

Reaching Every District (RED) approach: a way to improve immunization performance

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Validity of reported vaccination coverage in 45 countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Accuracy and quality of immunization information systems in forty-one low income countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Measuring coverage in MNCH: total survey error and the interpretation of intervention coverage estimates from household surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Validity of vaccination cards and parental recall to estimate vaccination coverage: a systematic review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Evaluation of a measles-smallpox vaccination campaign by a sero-epidemiologic method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

The sensitivity of BCG scar as an indicator of previous vaccination among Sudanese infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000–2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Immunologic correlates of protection induced by vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Correlates of protection induced by vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Vaccines: correlates of vaccine-induced immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Duration of humoral immunity to common viral and vaccine antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Immunological mechanisms of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Antiviral antibody responses: the two extremes of a wide spectrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Measuring the accuracy of diagnostic systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Improving sensitivity of oral fluid testing in IgG prevalence studies: application of mixture models to a rubella antibody survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Diagnosis using predictive probabilities without cut-offs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Sero-Surveillance to Assess Immunity to Rubella and Assessment of Immunogenicity and Safety of a Single dose of Rubella Vaccine in School Girls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Assessment of mumps virus-specific antibodies by different serological assays: which test correlates best with mumps immunity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Model selection methodology for inter-laboratory standardisation of antibody titres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Standardization of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Sero-epidemiology of mumps in western Europe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

WHO and UNICEF estimates of national infant immunization coverage: methods and processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

A mid-term assessment of progress towards the immunization coverage goal of the Global Immunization Vision and Strategy (GIVS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Antibodies to diphtheria, tetanus and pertussis in infants before and after immunization with DTP (Triple Antigen) vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

A population-based serologic survey of immunity to tetanus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Why do pertussis vaccines fail?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Oral fluid testing during 10 years of rubella elimination, England and Wales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Agreement of rubella IgG antibody measured in serum and dried blood spots using two commercial enzyme-linked immunosorbent assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Whole blood samples as an alternative to serum for detection of immunity to measles virus by ELISA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Validation of an anti-measles virus-specific IgG assay with oral fluid samples for immunization surveillance in Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Measles vaccination coverage estimates from surveys, clinic records, and immune markers in oral fluid and blood: a population-based cross-sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

Results from nationwide hepatitis B serosurvey in Cambodia using simple and rapid laboratory test: implications for National Immunization Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.07.005

10.1016/J.VACCINE.2014.07.005

7 January 2021

Identifiers

DOI

1 reference

31 August 2017

1 reference